Levesure 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal firing and reduce seizure activity. This medication is typically prescribed as adjunctive therapy in adults and pediatric patients aged four years and older. Levesure 500 Tablet is generally well tolerated, with common adverse effects including somnolence, dizziness, headache, and fatigue. It is important to administer the drug consistently, with or without food, and to follow the prescribed dosing regimen to maintain therapeutic plasma concentrations. Dose adjustments may be necessary in patients with renal impairment. Caution is advised in patients with a history of psychiatric disorders, as behavioral abnormalities such as irritability, depression, and suicidal ideation have been reported. Regular monitoring and clinical evaluation are recommended to assess efficacy and tolerability. Levesure 500 Tablet should be stored at room temperature, away from moisture and direct light. Patients should consult their healthcare provider before initiating or discontinuing therapy.